P. Ren et al., EXPRESSION OF GROWTH-FACTORS IN CHICKEN GROWTH-PLATE WITH SPECIAL REFERENCE TO TIBIAL DYSCHONDROPLASIA, Journal of Comparative Pathology, 116(3), 1997, pp. 303-320
Immunoreactive growth factors were identified in chick embryonic carti
lage and bone, and in the growth plate of normal tibiotarsi and tibiot
arsi affected with tibial dyschondroplasia (TD). A specific pattern of
temporal and spatial expression was observed for each growth factor.
Transforming growth factor beta and alpha (TGF beta and TGF alpha) and
epidermal growth factor (EGF) were briefly expressed in chondrocytes
of early chick embryos. Immunolabelling for TGF beta then gradually sh
ifted into cartilaginous matrix and was not observed in cytoplasm of h
ypertrophic chondrocytes until the late embryonic and posthatch stages
. The distribution and intensity of TGF beta labelling was the same in
chondrocytes of the TD and normal growth plate. Insulin-like growth f
actor I (IGF-I) labelling persisted from the early embryonic stage to
the end of the mid-stage and then disappeared from chondrocytes. IGF-I
appeared again in chondrocytes 1-2 days before hatching. After hatchi
ng, the labelling intensified in prehypertrophic and hypertrophic chon
drocytes. TD lesions displayed IGF-I in the distal region, mainly in c
hondrocytes around small blood vessels. EGF reappeared in proliferativ
e and hypertrophic chondrocytes of the mid-embryonic stage. By day 18
after hatching, EGF was present mainly in prehypertrophic and hypertro
phic chondrocytes. EGF was demonstrated only in distal proliferative a
nd early prehypertrophic chondrocytes of the dyschondroplastic growth
plate. TGF alpha was identified in hypertrophic chondrocytes adjacent
to the periosteum and in the distal tip of the mid-embryonic growth pl
ate. With progressing ossification, TGF alpha labelling intensified in
the embryonic hypertrophic chondrocytes. In the TD growth plate at da
y 18 after hatching, TGF alpha expression was limited to 1-3 concentri
c layers of chondrocytes surrounding blood vessels. (C) 1997 W.B. Saun
ders Company Limited.